THE WOODLANDS, Texas, May 26, 2011 /PRNewswire/ — McKesson Specialty Care
Solutions | US Oncology, a division of McKesson Corporation, announced
today that four physicians affiliated with
US Oncology Research and the
United Network of US Oncology will give oral presentations at
the 47th Annual Meeting of the American Society of
Clinical Oncology (ASCO) held June 3 – 7 at
McCormick Place in Chicago.
ASCO is the world’s leading professional organization
representing physicians who care for people with cancer. More than
70 McKesson Specialty Care Solutions | US Oncology affiliated
oncology experts have contributed to more than 60 studies being
featured at this year’s major medical meeting.
“US Oncology Research affiliated investigators are consistently
on the cutting edge when it comes to the life-changing therapies of
the future,” said Nicholas
Vogelzang, MD, oncologist at Comprehensive Cancer Centers of
Nevada, co-chair of the Genitourinary Committee for US Oncology
Research, and the communications chair of the 2011 ASCO Annual
Meeting. “When it comes to advancing cancer care, these
investigators are contributing in a major way. Take the MEK
inhibitor study for example. The investigators understand molecular
mechanisms, work with companies which have drugs targeting those
mechanisms and use them to successfully treat patients in their
practices. This is translational research at its best.”The four
studies being presented orally at ASCO by US Oncology Research
affiliated physicians are as
‘/>”/>
SOURCE
